Neurotransmitter and Imaging Studies in Anorexia Nervosa: New Targets for Treatment
Journal:
Current Drug Targets - CNS & Neurological Disorders
Volume:
2
Page:
61-72
Author(s):
Nicole C. Barbarich, Walter H. Kaye and David Jimerson
Probiotics as Biotherapeutic Agents: Present Knowledge and Future Prospects
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
175-191
Author(s):
A. Mercenier, S. Pavan and B. Pot
Cancer Chemoprevention Drug Targets
Journal:
Current Drug Targets
Volume:
4
Page:
45-54
Author(s):
K. Krishnan, S. Campbell, F. Abdel-Rahman, S. Whaley and W. L. Stone
Membrane Receptors for Vitamin D Steroid Hormones: Potential NewDrug Targets
Journal:
Current Drug Targets
Volume:
4
Page:
67-76
Author(s):
M. C. Farach-Carson and I. Nemere
Non-Camptothecin DNA Topoisomerase I Inhibitors in Cancer Therapy
Journal:
Current Topics in Medicinal Chemistry
Volume:
3
Page:
305-320
Author(s):
Meng Ling-hua, Liao Zhi-yong and Yves Pommier
Dual Topoisomerase I / II Inhibitors in Cancer Therapy
Journal:
Current Topics in Medicinal Chemistry
Volume:
3
Page:
339-353
Author(s):
William A. Denny and Bruce C. Baguley
Transmission and Immunopathogenesis of FIV in Cats as a Model for HIV
Journal:
Current HIV Research
Volume:
1
Page:
15-29
Author(s):
Mary Jo Burkhard and Gregg A. Dean
Update on D-Ala-Peptide T-Amide (DAPTA): A Viral Entry Inhibitor that Blocks CCR5 Chemokine Receptors
Journal:
Current HIV Research
Volume:
1
Page:
51-67
Author(s):
Michael R. Ruff, Maria Polianova, Quan-en Yang, Gifford S. Leoung, Francis W. Ruscetti and Candace B. Pert
Cytochrome P450-based Gene Therapy for Cancer Treatment: From Concept to the Clinic
Journal:
Current Drug Metabolism
Volume:
3
Page:
609-622
Author(s):
Youssef Jounaidi
Gap Junction Synthesis and Degradation as Therapeutic Targets
Journal:
Current Drug Targets
Volume:
3
Page:
409-416
Author(s):
Eric C. Beyer and Viviana M. Berthoud